Beleave Inc. Stock Canadian Securities Exchange
Equities
BE
CA0775611084
Pharmaceuticals
Sales 2018 | - | Sales 2019 | 2.37 3.26 | Capitalization | 30.37M 41.64M |
---|---|---|---|---|---|
Net income 2018 | -12M -16.45M | Net income 2019 | -33M -45.25M | EV / Sales 2018 | - |
Net cash position 2018 | 5.2M 7.13M | Net Debt 2019 | 10.32M 14.14M | EV / Sales 2019 | 17,137,012 x |
P/E ratio 2018 |
-4.72
x | P/E ratio 2019 |
-0.76
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 98.39% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 00-05-25 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-14 |
Kevin Keagan
BRD | Director/Board Member | - | 18-10-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-14 |
Founder | - | 00-05-25 | |
Kevin Keagan
BRD | Director/Board Member | - | 18-10-23 |
1st Jan change | Capi. | |
---|---|---|
+39.54% | 6.12B | |
-16.47% | 4.44B | |
-10.16% | 3.14B | |
-0.71% | 3.03B | |
-1.06% | 2.57B | |
+40.09% | 1.87B | |
-0.76% | 1.63B | |
-11.19% | 1.62B | |
-12.74% | 1.53B |